United States · Financial press · Investor's Business Daily
Arcus Dips, But Recovers From Steep Losses, On Merck-Rivaling Cancer Data
Arcus Biosciences touted its Merck-rivaling kidney cancer treatment results Tuesday, but shares took a swim. The post Arcus Dips, But Recovers From Steep Losses, On Merck-Rivaling…
Read the full article on Investor's Business Daily Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)
